Ataxin-7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats

Annals of Neurology

Volumn 56, Issue 3, 2004, Pages 448-452

  Ansorge, Olaf ^a,d   Giunti, Paola ^a   Michalik, Andrej ^b   Van Broeckhoven, Christine ^b   Harding, Brian ^c   Wood, Nicholas ^a   Scaravilli, Francesco ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 7; BRAIN PROTEIN; GLUTAMINE; POLYGLUTAMINE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR SYSTEM; CASE REPORT; CELL LOSS; FEMALE; GENE; HIPPOCAMPUS; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN AGGREGATION; SCA7 GENE; SPINOCEREBELLAR ATAXIA TYPE 7; SPINOCEREBELLAR DEGENERATION; SYNDROME DELINEATION; UBIQUITINATION;

CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NERVE TISSUE PROTEINS; NEURONS; PEDIGREE; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEATS; UBIQUITIN;

EID: 4444292910     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20230     Document Type: Article

References (20)

1. Michalik A, Martin JJ, Van Broeckhoven C. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy. Eur J Hum Genet 2004;12:2-15.
2. Johansson J, Forsgren L, Sandgren O, et al. Expanded CAG repeats in Swedish spinocerebellar ataxia type 7 (SCA7) patients: effect of CAG repeat length on the clinical manifestation. Hum Mol Genet 1998;7:171-176.
3. Benton CS, de Silva R, Rutledge SL, et al. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology 1998;51:1081-1086.
4. van de Warrenburg BP, Frenken CW, Ausems MG, et al. Striking anticipation in spinocerebellar ataxia type 7: the infantile phenotype. J Neurol 2001;248:911-914.
5. Watase K, Weeber EJ, Xu B, et al. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 2002;34:905-919.
6. Yoo SY, Pennesi ME, Weeber EJ, et al. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron 2003;37:383-401.
7. Giunti P, Stevanin G, Worth PF, et al. Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation. Am J Hum Genet 1999;64:1594-1603.
8. David G, Abbas N, Stevanin G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997;17:65-70.
9. Mauger C, Del Favero J, Ceuterick C, et al. Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody. Brain Res Mol Brain Res 1999;74:35-43.
10. Jonasson J, Strom AL, Hart P, et al. Expression of ataxin-7 in CNS and non-CNS tissue of normal and SCA7 individuals. Acta Neuropathol (Berl) 2002;104:29-37.
11. Forsgren L, Libelius R, Holmberg M, et al. Muscle morphology and mitochondrial investigations of a family with autosomal dominant cerebellar ataxia and retinal degeneration mapped to chromosome 3p12-p21.1. J Neurol Sci 1996;144:91-98.
12. Holmberg M, Duyckaerts C, Durr A, et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 1998;7:913-918.
13. Michalik A, Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet 2003;12(suppl 21:R173-R186.
14. Stenoien DL, Mielke M, Mancini MA. Intranuclear ataxinl inclusions contain both fast- and slow-exchanging components. Nat Cell Biol 2002;4:806-810.
15. Warrick JM, Paulson HL, Gray Board GL, et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 1998;93:939-949.
16. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001;292:1552-1555.
17. Gutekunst CA, Li SH, Yi H, et al. Nuclear and neuropil aggregares in Huntington's disease: relationship to neuroparhology. J Neurosci 1999;19:2522-2534.
18. Mende-Mueller LM, Toneff T, Hwang SR, et al. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J Neurosci 2001;21:1830-1837.
19. Gray DA. Damage control - a possible non-proteolytic role for ubiquitin in limiting neurodegeneration. Neuropathol Appl Neurobiol 2001;27:89-94.
20. Hicke L. Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2001;2:195-201.